Parallel Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Parallel Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-92	Closed	-$3.62K	–	3541
2023 Q2	$3.62K	Hold	92	–	–	﹤0.01%	2545
2023 Q1	$2.24K	Hold	92	–	–	﹤0.01%	2732
2022 Q4	$1.97K	Buy	+92	New	+$1.96K	﹤0.01%	2689
2017 Q1	–	Sell	-42	Closed	–	–	2107
2016 Q4	$0	Buy	+42	New	+$1.25K	﹤0.01%	1803

Parallel Advisors's ISEE Position: Q3 2023 in Review

Parallel Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 92 shares — an estimated $3.62K sold.

Parallel Advisors first reported a position in ISEE in Q4 2016 and held it in 4 quarters. The position peaked at $3.62K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Parallel Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Parallel Advisors sold 92 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $3.62K.
Parallel Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 4 quarters.
Parallel Advisors's IVERIC bio, Inc. Common Stock position peaked at $3.62K in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Parallel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.